Quantcast

Latest Parkinson's disease Stories

2014-10-20 12:29:44

The Parkinson Alliance Reports Findings Pertaining to Autonomic Dysfunction in Parkinson's KINGSTON, N.J., Oct. 20, 2014 /PRNewswire-USNewswire/ -- New findings from The Parkinson Alliance (PA) survey entitled "Autonomic Dysfunction in Parkinson's Disease With and Without Deep Brain Stimulation" show that autonomic dysfunction was highly prevalent in Parkinson's disease (PD), regardless of age and disease duration. The autonomic nervous system controls a number of functions in the...

2014-10-15 16:29:22

COLUMBUS, Ohio, Oct. 15, 2014 /PRNewswire/ -- OhioHealth "Delay the Disease", an evidenced-based fitness program designed for people with Parkinson's Disease, is one of the newest members of the OhioHealth family of neuroscience programs. The community-based wellness program is designed to empower those living with Parkinson's Disease by optimizing their physical function and helping to delay the progression of symptoms associated with Parkinson's Disease. To view the multimedia...

2014-10-14 23:04:28

In its thirty-six year history, the American Parkinson Disease Association Cozias Fellowship has been awarded to only twenty-eight scientific investigators New York, NY (PRWEB) October 14, 2014 The American Parkinson Disease Association is pleased to announce the application process for this prestigious award is now open. The George C. Cotzias, MD Memorial Fellowship was developed by the American Parkinson Disease Association (APDA) in 1979 to honor Dr. Cotzias who was a pathfinder in...

2014-10-14 12:26:46

Sales of a Novel Antipsychotic and an Improved Rescue Therapy Will Contribute Approximately $1 Billion to the PD Market in 2023, According to Findings from Decision Resources Group BURLINGTON, Mass., Oct. 14, 2014 /PRNewswire/ -- Decision Resources Group finds that the Parkinson's disease (PD) pharmacotherapy market will grow 5 percent annually from $2.3 billion in 2013 to $3.8 billion in 2023. This growth will be fueled by the launch of several emerging therapies--including new molecular...

2014-10-14 08:34:19

Allied Team Training for Parkinson's Disease will be held in San Diego, CA this November MIAMI, Oct. 14, 2014 /PRNewswire-USNewswire/ -- The National Parkinson Foundation (NPF) and the International Parkinson and Movement Disorder Society (MDS) Pan American Section (MDS-PAS) announced today a collaborative partnership to offer a three-day course to teach team care and increase knowledge of Parkinson's disease (PD). The course, Allied Team Training for Parkinson's Disease (ATTP) will...

2014-10-14 08:33:10

Robust Clinical Development Programs Across Sellas' Portfolio of Drugs and Biologics ZUG, Switzerland and NEW YORK, Oct. 14, 2014 /PRNewswire/ -- SELLAS Life Sciences Group (SELLAS), a Swiss-based development-stage biopharmaceutical company, today announced that it has signed a definitive master service agreement with Pharmaceutical Product Development (PPD), a leading global contract research organization (CRO), to advance and expand clinical and regulatory development across...

2014-09-30 23:13:38

Evidence Based Rehab Techniques for Parkinsons, Multiple Sclerosis and Peripheral Neuropathy is a new OT PT Continuing Education courses designed to deliver new rehab information on the treatment of Multiple Sclerosis and Peripheral Neuropathy. Franklin, TN (PRWEB) September 30, 2014 Neuromuscular and central nervous system diseases affect millions of people throughout the United States and worldwide. It is estimated that 50,000-60,000 new cases of Parkinson’s Disease are diagnosed each...

2014-09-30 23:09:38

The American Parkinson Disease Association has announced $1.1 million in new research funding for 2014-2015 supporting seven Research grants, three Post-Doctoral Fellowships, and eight Centers of Advanced Research. New York, NY (PRWEB) September 30, 2014 The American Parkinson Disease Association is pleased to award research funding supporting seven Research grants to junior investigators pursuing research in Parkinson’s disease, three Post-Doctoral Fellowships to support post-doctoral...

2014-09-10 08:32:09

MELBOURNE, Australia, Sept. 10, 2014 /PRNewswire/ -- Global Kinetics Corporation, a leading mobile health technologies company, today announced that the U.S. Food and Drug Administration (FDA) has cleared the marketing of the company's Personal KinetiGraph(TM) (PKG(TM)) technology designed to improve the assessment and monitoring of symptoms of Parkinson's disease and other neurological disorders that affect movement. The Personal KinetiGraph is the first wrist-worn device approved in...

2014-09-09 12:29:41

Free Educational Seminars, Designed with Community Input, Provide Practical Tips for People with Parkinson's and Continuing Education for Health Professionals NEW YORK, Sept. 9, 2014 /PRNewswire-USNewswire/ -- The Parkinson's Disease Foundation® (PDF®) is pleased to announce its sixth series of PD ExpertBriefings, free interactive seminars presented by leaders in Parkinson's disease research and care. Designed for people living with Parkinson's disease and health care...


Word of the Day
reremouse
  • A bat.
The word 'reremouse' comes from Middle English reremous, from Old English hrēremūs, hrērmūs ("bat"), equivalent to rear (“to move, shake, stir”) +‎ mouse.
Related